352 related articles for article (PubMed ID: 19085183)
1. Characterization of hydroxyl radical modified GAD65: a potential autoantigen in type 1 diabetes.
Khan MW; Sherwani S; Khan WA; Ali R
Autoimmunity; 2009 Feb; 42(2):150-8. PubMed ID: 19085183
[TBL] [Abstract][Full Text] [Related]
2. Immuno-chemistry of hydroxyl radical modified GAD-65: A possible role in experimental and human diabetes mellitus.
Moinuddin ; Ansari NA; Shahab U; Habeeb S; Ahmad S
IUBMB Life; 2015 Oct; 67(10):746-56. PubMed ID: 26362234
[TBL] [Abstract][Full Text] [Related]
3. Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition.
Daw K; Ujihara N; Atkinson M; Powers AC
J Immunol; 1996 Jan; 156(2):818-25. PubMed ID: 8543838
[TBL] [Abstract][Full Text] [Related]
4. Reactive oxygen species damaged human serum albumin in patients with type 1 diabetes mellitus: biochemical and immunological studies.
Rasheed Z; Ali R
Life Sci; 2006 Nov; 79(24):2320-8. PubMed ID: 16945391
[TBL] [Abstract][Full Text] [Related]
5. Detection of antibodies against both isoforms of glutamate decarboxylase in BB/OK rats by western blotting and immuno trapping enzyme activity assay.
Lühder F; Woltanski KP; Hamann J; Klöting I; Ziegler B; Ziegler M
Diabetes Res; 1992; 20(4):97-107. PubMed ID: 1345008
[TBL] [Abstract][Full Text] [Related]
6. GAD65 as a prototypic autoantigen.
Fenalti G; Rowley MJ
J Autoimmun; 2008 Nov; 31(3):228-32. PubMed ID: 18514483
[TBL] [Abstract][Full Text] [Related]
7. Detection and immunochemical characterization of glutamic acid decarboxylase autoantibodies in patients with autoimmune diabetes mellitus.
Villalba A; Iacono RF; Valdez SN; Poskus E
Autoimmunity; 2008 Mar; 41(2):143-53. PubMed ID: 18324484
[TBL] [Abstract][Full Text] [Related]
8. Frequency of diabetes and thyroid autoantibodies in patients with autoimmune endocrine disease from Cameroon.
Hawa MI; Picardi A; Costanza F; D'Avola D; Beretta Anguissola G; Guglielmi C; Mottini G; Fezeu L; Mbanya JC; Leslie RD; Pozzilli P
Clin Immunol; 2006; 118(2-3):229-32. PubMed ID: 16298164
[TBL] [Abstract][Full Text] [Related]
9. Antigenic determinants to GAD autoantibodies in patients with type 1 diabetes with and without autoimmune thyroid disease.
Park H; Yu L; Kim T; Cho B; Kang J; Park Y
Ann N Y Acad Sci; 2006 Oct; 1079():213-9. PubMed ID: 17130557
[TBL] [Abstract][Full Text] [Related]
10. Carboxypeptidase-H autoantibodies differentiate a more latent subset of autoimmune diabetes from phenotypic type 2 diabetes among Chinese adults.
Yang L; Zhou ZG; Tan SZ; Huang G; Jin P; Yan X; Li X; Peng H; Hagopian W
Ann N Y Acad Sci; 2008 Dec; 1150():263-6. PubMed ID: 19120309
[TBL] [Abstract][Full Text] [Related]
11. Detection of autoantibodies against reactive oxygen species modified glutamic acid decarboxylase-65 in type 1 diabetes associated complications.
Khan MW; Banga K; Mashal SN; Khan WA
BMC Immunol; 2011 Mar; 12():19. PubMed ID: 21385406
[TBL] [Abstract][Full Text] [Related]
12. Detection of pancreatic islet 64,000 M(r) autoantigens in insulin-dependent diabetes distinct from glutamate decarboxylase.
Christie MR; Hollands JA; Brown TJ; Michelsen BK; Delovitch TL
J Clin Invest; 1993 Jul; 92(1):240-8. PubMed ID: 8325989
[TBL] [Abstract][Full Text] [Related]
13. Comparison of immunoassays for the detection of anti-GAD65 autoantibodies in patients with diabetes mellitus.
Pfützner A; Harzer O; Kunt T; Forst T; Abdollahnia N; Löbig M; Krauss H; Engelbach M; Kann P; Beyer J
Clin Lab; 2000; 46(5-6):275-9. PubMed ID: 10853236
[TBL] [Abstract][Full Text] [Related]
14. [Prevalence of anti-GAD autoantibodies in Tunisian children with type 1 diabetes].
Elkadhi A; Khelifi N; Abid A; Nagati K; Jenhani F; Ben Rayana MC
Tunis Med; 2002 May; 80(5):281-5. PubMed ID: 12534034
[TBL] [Abstract][Full Text] [Related]
15. Development and progression of diabetic retinopathy in patients with Type 1 diabetes who are positive for GAD autoantibody.
Mimura T; Funatsu H; Uchigata Y; Kitano S; Shimizu E; Noma H; Amano S; Araie M; Iwamoto Y; Hori S
Diabet Med; 2004 Jun; 21(6):559-62. PubMed ID: 15154939
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the GAD65-GAD65 autoantibody interaction.
Coco G; Chen S; Powell M; Brooking H; Zanchetta R; Betterle C; Smith BR; Furmaniak J
Clin Chim Acta; 2008 May; 391(1-2):51-9. PubMed ID: 18328264
[TBL] [Abstract][Full Text] [Related]
17. Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetes.
Westerlund A; Ankelo M; Ilonen J; Knip M; Simell O; Hinkkanen AE
J Autoimmun; 2005 Mar; 24(2):153-67. PubMed ID: 15829408
[TBL] [Abstract][Full Text] [Related]
18. Distinct antigenic features of linear epitopes at the N-terminus and C-terminus of 65 kDa glutamic acid decarboxylase (GAD65): implications for autoantigen modification during pathogenesis.
Al-Bukhari TA; Radford PM; Bouras G; Davenport C; Trigwell SM; Bottazzo GF; Lai M; Schwartz HL; Tighe PJ; Todd I
Clin Exp Immunol; 2002 Oct; 130(1):131-9. PubMed ID: 12296864
[TBL] [Abstract][Full Text] [Related]
19. Comparison of a new anti-glutamic acid decarboxylase (GAD) enzyme-linked immunosorbent assay (ELISA) with radioimmunoassay methods: a multicenter study.
Wild T; Scherbaum WA; Gleichmann H; Landt M; Santiago J; Endl J; Landgraf R; Cavallo MG; Ganz M; Pozzilli P
Horm Metab Res; 1997 Aug; 29(8):403-6. PubMed ID: 9288579
[TBL] [Abstract][Full Text] [Related]
20. [The glutamic acid decarboxylase (GAD) antibodies and their clinical significance].
Ogata K; Ohta K; Kubo H; Yamaguchi A; Watanabe H
Rinsho Byori; 1995 May; 43(5):468-71. PubMed ID: 7783365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
